SOST and metabolic dysfunction-associated steatotic liver disease: Zhou et al. [37] examined circulating SOST levels in patients with non-alcoholic fatty liver disease (NAFLD) versus healthy subjects, and they found that circulating SOST levels are significantly lower in patients with NAFLD than in control subjects; moreover, SOST levels in liver and bone are lower in HFD-fed mice than in control subjects.